Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale GOLDSMITH MARK A sold 8,165 shares at $25.90 ($211,488)
  2. 4 Planned sale General Counsel sold 1,229 shares at $25.90 ($31,833)
  3. 4 Planned sale Kelsey Stephen Michael sold 2,088 shares at $25.90 ($54,083)
  4. 4 Planned sale Chief Operating Officer sold 7,993 shares at an average $26.36 ($210,707)
  5. 4 Planned sale Chief Operating Officer sold 5,000 shares at $25.00 ($125,000)
  6. 4 Planned sale General Counsel sold 1,500 shares at $21.70 ($32,545)
  7. 4 Grant or award Director acquired 90,487 shares (grant or award)
  8. 4 Grant or award Director acquired 2,091,672 shares (grant or award)
  9. 4 Grant or award Director acquired 1,457,211 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Exercise or conversion Chief Operating Officer acquired 7,500 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 35,000 shares (option exercise)
  13. 4 Exercise or conversion Chief Financial Officer acquired 24,524 shares (option exercise)
  14. 4 Planned sale Chief Operating Officer sold 25,000 shares at an average $33.95 ($848,806)
  15. 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at $29.05 ($484,130)
  16. 4 Planned sale General Counsel sold 2,000 shares at an average $28.20 ($56,394)
  17. 4 Open-market sale Kelsey Stephen Michael sold 2,060 shares at $31.31 ($64,500)
  18. 4 Open-market sale Director sold 8,054 shares at $31.31 ($252,175)
  19. 4 Open-market sale General Counsel sold 1,214 shares at $31.31 ($38,011)
  20. 4 Open-market sale Chief Financial Officer sold 1,427 shares at $31.31 ($44,680)

Page 11 of 21 · 414 filings